Paul Tudor Jones II acquired 735 Thousand Royalty Pharma plc shares worth $24.3 Million. That's 0.30% of their equity portfolio (70th largest holding). The first Royalty Pharma plc trade was made in Q2 2023. Since then Paul Tudor Jones II bought shares four more times and sold shares on two occasions. The stake costed the investor $20.7 Million, netting the investor a gain of 18% so far.